You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
What does it feel like to move through a world designed to limit and exclude you? What are the joys and pains of holidays for people of colour, when guidebooks are never written with them in mind? How are black lives today impacted by the othering legacy of colonial cultures and policies? What can travel tell us about our sense of self, of home, of belonging and identity? Why has the world order become hostile to human mobility, as old as humanity itself, when more people are on the move than ever? Nanjala Nyabola is constantly exploring the world, working with migrants and confronting complex realities challenging common assumptions - both hers and others'. From Nepal to Botswana, Sicily to Haiti, New York to Nairobi, her sharp, humane essays ask tough questions and offer surprising, deeply shocking and sometimes funny answers. It is time we saw the world through her eyes.
The Human Right to Science offers a thorough and systematic analysis of the right to science in all of its critical aspects. Authored by experts in international law and science policy, the book meticulously explores the right's origins, development, and normative content. In doing so, it uncovers previously unarticulated entitlements and obligations, offering new insights on human rights interconnections.
The first serious, extended effort to use a human rights-based approach to address the scientific issues affecting society and the often-neglected human right to science.
The UN celebrated its 70th anniversary in 2015. In the Volume Reforming the UN: A Chronology by Joachim Müller an exciting story is told describing the evolution of the UN through the main change initiatives applied by each Secretary-General, characterized by political confrontations, crises of confidence and organizational constraints. Initiatives included approving the Sustainable Development Goals, strengthening peacekeeping, enlarging the Security Council, establishing mechanisms to protect human rights, improving aid efficiency, and reforming management practices. This story is completed by a Chronology of Reform Events to enhance the transparency of parallel, multi-layer reform tracks. Lessons learned highlight the main drivers of changes, the interests and constraints, and the dynamics of the reform process: valuable insight for capitalizing on future change opportunities.
There are fewer grounds today than in the past to deplore a North‑South divide in research and innovation. This is one of the key findings of the UNESCO Science Report: towards 2030. A large number of countries are now incorporating science, technology and innovation in their national development agenda, in order to make their economies less reliant on raw materials and more rooted in knowledge. Most research and development (R&D) is taking place in high-income countries, but innovation of some kind is now occurring across the full spectrum of income levels according to the first survey of manufacturing companies in 65 countries conducted by the UNESCO Institute for Statistics and summariz...
The human right to science, outlined in the 1948 Universal Declaration of Human Rights and repeated in the 1966 International Covenant on Economic, Social, and Cultural Rights, recognizes everyone’s right to “share in scientific advancement and its benefits” and to “enjoy the benefits of scientific progress and its applications.” This right also requires state parties to develop and disseminate science, to respect the freedom of scientific research, and to recognize the benefits of international contacts and co-operation in the scientific field. The right to science has never been more important. Even before the COVID-19 health crisis, it was evident that people around the world in...
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed with multidrug-resistant tuberculosis (MDR TB)-a disease caused by strains of Mycobacterium tuberculosis (M.tb.) resistant to two primary TB drugs (isoniazid and rifampicin)-face lengthy treatment regimens of 2 years or more with daily, directly observed treatment (DOT) with SLDs that are less potent, more toxic, and more expensive than those used to treat drug-susceptible TB. From 2000 to 2009, only 0.2-0.5 percent o...